We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Aigenpulse Introduces Novel Data Intelligence Platform to Expedite Drug Discovery and Development content piece image
Product News

Aigenpulse Introduces Novel Data Intelligence Platform to Expedite Drug Discovery and Development

Aigenpulse has introduced a new state-of-the-art data intelligence platform that is designed to expedite the drug discovery and development process.
TALLC Granted UK Patent for SmartCelle Ocular Drug Delivery Technology content piece image
Product News

TALLC Granted UK Patent for SmartCelle Ocular Drug Delivery Technology

TALLC has announced that the United Kingdom Intellectual Property Office (IPO) has granted the first in a series of SmartCelle smart micelle patents covering their novel nanotechnology for ocular drug delivery.
Byondis’ Investigational Antibody-Drug Conjugate Selected for Trial in Early-Stage Breast Cancer content piece image
Product News

Byondis’ Investigational Antibody-Drug Conjugate Selected for Trial in Early-Stage Breast Cancer

Byondis has announced that Quantum Leap selected the company’s investigational antibody-drug conjugate SYD985 for a new investigational treatment arm in its ongoing I-SPY 2 TRIAL™ for neoadjuvant treatment of locally advanced breast cancer.
Rentschler Biopharma and Vetter Team Up to Optimize Time-To-Market content piece image
Product News

Rentschler Biopharma and Vetter Team Up to Optimize Time-To-Market

Vetter and Rentschler Biopharma have announced their strategic collaboration to enhance their services and offer complementary skills and experience along the biopharmaceutical value chain.
Freyr Launches COVID-19 Web Platform with Regulatory Information for Manufacturers content piece image
Product News

Freyr Launches COVID-19 Web Platform with Regulatory Information for Manufacturers

Freyr has announced the launch of a web platform for COVID-19 driven with real-time information for manufacturers to help them get to market and support them in emergency use authorizations with global regulatory authorities.
My Personal Therapeutics and Pentavere Receive EUREKA Funding to Support AI-based Personalized Cancer Treatment Plans content piece image
Product News

My Personal Therapeutics and Pentavere Receive EUREKA Funding to Support AI-based Personalized Cancer Treatment Plans

My Personal Therapeutics and Pentavere have announced their successful EUREKA Collaborative R&D: AI and Quantum Technologies Competition award for project titled "Utilisation of AI to develop Personalised Treatment Plans for cancer".
Havn Life Launches to Develop Psilocybin Products for Research content piece image
Product News

Havn Life Launches to Develop Psilocybin Products for Research

Havn Life is a biotechnology company aimed at improving cognitive performance through the standardized extraction of psychoactive compounds and the development of natural health care products from novel compounds.
RxRx19: Over 300,000 Cellular Images for COVID-19 Therapeutic Research content piece image
Product News

RxRx19: Over 300,000 Cellular Images for COVID-19 Therapeutic Research

More than 305,000 high-resolution, multi-channel COVID-19 cellular images captured in less than four weeks with Molecular Devices ImageXpress® Micro Confocal High-Content Imaging System are now available to the scientific community.
NanoImaging Services Expands To Support CryoEM-enabled Drug Discovery content piece image
Product News

NanoImaging Services Expands To Support CryoEM-enabled Drug Discovery

NanoImaging Services, Inc. has announced the opening of a new facility to support its growing customer base requiring cryoEM for drug discovery and vaccine development applications. COVID-19 projects are receiving prioritization.
Dotmatics Acquires BioBright to Accelerate Laboratory Data Automation content piece image
Product News

Dotmatics Acquires BioBright to Accelerate Laboratory Data Automation

Dotmatics Ltd. has announced that it has entered into an agreement to acquire BioBright LLC, aiming to create a unique combination of lab data capture, data processing, electronic lab notebook (ELN) and data analytics capability from a single supplier.
Advertisement